Introduction: An overview of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study

CNS Spectrums

Volumn 11, Issue SUPPL. 7, 2006, Pages 4-8

  McEvoy, Joseph P ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b John Umstead Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; FLUPHENAZINE DECANOATE; NEUROLEPTIC AGENT; OLANZAPINE; PERPHENAZINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

AKATHISIA; CLINICAL PRACTICE; CLINICAL TRIAL; DRUG APPROVAL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSTONIA; EDITORIAL; HEALTH CARE COST; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; INFORMED CONSENT; INTERVENTION STUDY; MAXIMUM ALLOWABLE CONCENTRATION; METHODOLOGY; OUTCOME ASSESSMENT; PARKINSONISM; PATIENT SELECTION; PRIORITY JOURNAL; PUBLIC HEALTH; SCHIZOPHRENIA; SIDE EFFECT; TREMOR; WEIGHT GAIN; ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; FEMALE; MALE; MIDDLE AGED; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; TIME;

ADOLESCENT; ADULT; AGED; ANTIPSYCHOTIC AGENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; SCHIZOPHRENIA; TIME FACTORS;

EID: 33746522294     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/s1092852900026626     Document Type: Editorial

References (4)

1. Lieberman JA, Stroup TS, McEvoy JP, et al, for the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353(12):1209-1223.
2. Jaffe AB, Levine J. Efficacy and effectiveness of first- and second-generation antipsychotics in schizophrenia. J Clin Psychiatry. 2003;65(suppl 17):3-6.
3. Stroup TS, McEvoy JP, Swartz MS, et al. The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial design and protocol development. Schizophrenia Bull. 2003;29(1):15-31.
4. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.